O'Neill Gilmore Neil
- SEC CIK
- 0001742084
In the past year, 4 open-market sale filings worth $80.0K and no purchases.
Current role at each company
- EDIT Editas Medicine, Inc.CEOas of Sep 4, 2026
- UBX Unity Biotechnology, Inc.Directoras of Jun 21, 2024
- APTX Aptinyx Inc.Directoras of May 31, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $80.0K
- 4 filings
- Net
- −$80.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists O'Neill Gilmore Neil as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EDIT Editas Medicine, Inc.
CEO12 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 (view filing) | Jun 5 | 2 days | O'Neill Gilmore NeilCEO | SSale | −6.49K | $9.50 | −$61.6K | −4.7%130.2K after | 10b5-1 |
| Mar 5, 2024 (view filing) | Mar 5 | Same day | O'Neill Gilmore NeilCEO | SSale | −77.8K | $9.42 | −$733.1K | −19.2%327.5K after | 10b5-1 |
| Jun 6, 2024 (view filing) | Jun 4 | 2 days | O'Neill Gilmore NeilCEO | SSale | −12.2K | $5.50 | −$67.1K | −3.7%315.3K after | 10b5-1 |
| Sep 6, 2024 (view filing) | Sep 4 | 2 days | O'Neill Gilmore NeilCEO | SSale | −1.55K | $3.42 | −$5.32K | −0.5%313.7K after | 10b5-1 |
| Dec 5, 2024 (view filing) | Dec 3 | 2 days | O'Neill Gilmore NeilCEO | SSale | −1.62K | $2.08 | −$3.37K | −0.5%312.1K after | 10b5-1 |
| Mar 5, 2025 (view filing) | Mar 4 | 1 day | O'Neill Gilmore NeilCEO | SSale | −16.6K | $1.71 | −$28.4K | −5.3%295.5K after | 10b5-1 |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | O'Neill Gilmore NeilCEO | SSale | −15.2K | $1.72 | −$26.1K | −5.1%280.3K after | 10b5-1 |
| Sep 4, 2025 (view filing) | Sep 3 | 1 day | O'Neill Gilmore NeilCEO | SSale | −5.59K | $2.60 | −$14.5K | −2.0%274.7K after | 10b5-1 |
| Dec 4, 2025 (view filing) | Dec 3 | 1 day | O'Neill Gilmore NeilCEO | SSale | −5.60K | $2.15 | −$12.0K | −2.0%269.1K after | 10b5-1 |
| Mar 4, 2026 (view filing) | Mar 3 | 1 day | O'Neill Gilmore NeilCEO | SSale | −5.39K | $2.02 | −$10.9K | −2.0%263.7K after | 10b5-1 |